One in five members of Congress holds investments in AI infrastructure or model development companies, yet Congress has failed to pass meaningful AI regulation despite repeated warnings about systemic risks. This is not incompetence. It is conflict of interest operating as policy. For UK regulated firms — especially law practices, insurers, financial services firms and accountancies — this matters because the US regulatory environment has become a shadow that UK policymakers watch. When Congress does not regulate, the FCA, SRA, PRA and ICO face pressure to either fill the gap unilaterally or harmonise with a vacuum. Either way, UK firms end up in the middle, interpreting fragmented rules while American competitors operate under fewer constraints. The signal is clear: do not hold your breath for transatlantic regulatory convergence.

This story is part of a wider pattern: the AI industry has successfully fragmented governance across jurisdictions and captured key decision-makers. Europe moved first with the EU AI Act, establishing risk-based tiering that most UK firms now accept as inevitable. The US chose the opposite path — light-touch, sector-specific guidance that lets investors and vendors write the rules. The UK, unsure whether to follow Brussels or Washington, has done both and neither: FCA Consumer Duty PS22/9 demands explainability and fairness, the SRA Code requires competence and ethics, the ICO enforces UK GDPR against AI processing — but nobody has drawn a coherent line around what 'safe AI deployment' actually means in a professional services context. Congressional gridlock exported via investment flows means that line will not be drawn for you. You have to draw it yourself.

This is where Trovix's approach differs from the vendor consensus. Products like Harvey, Legora and Luminance were built on the assumption that regulation would eventually arrive and that compliance would follow industry self-certification. They still work well for specific document tasks — contract review, due diligence, legal research — but they do not solve the governance problem that this story exposes. A tool that reviews documents accurately is not enough if you cannot demonstrate to the FCA, SRA or ICO that you know why it made each decision, who signed off on it, and what would have happened if it had failed. Trovix Audit was built specifically around this gap: it logs every AI decision, tags it against your regulatory obligations (FCA, SRA, PRA, ICO, ISA UK, Lloyd's Blueprint Two, ISO 42001), and surfaces where your implementation drifts from your documented controls. When Congress leaves a vacuum, regulators fill it with forensic detail. You need that visibility now, not when an exam letter arrives.

For a mid-market practice right now: stop assuming that regulatory harmonisation will simplify your AI governance. It will not. Start treating AI implementation as a governance problem first and an efficiency problem second. Map your current AI use — whether that is ChatGPT for document drafting, Copilot for research, or bespoke intake automation — against your SRA obligations (Code of Conduct for Solicitors, Standards and Regulations), FCA Consumer Duty PS22/9 (if you advise clients), and ICO UK GDPR (for any personal data processing). Document what each tool does, who validated its accuracy, how you handle errors, and what happens if it fails. This is not optional compliance theatre: it is the actual work that congressional conflicts of interest have shifted onto your shoulders. Trovix Watch can help you stay ahead of the regulatory changes that will eventually come from this chaos, but the real work is in your current implementations. Do that first.

Source: Washington Post